The new insulin price cap: What you need to know

In early March, Eli Lilly made headlines after announcing a new $35 price cap on insulin for individuals with private insurance. Novo Nordisk and Sanofi made their own price reduction announcements shortly after Eli Lilly’s move.

Leave A Comment

Your email address will not be published. Required fields are marked *